Immunovia publishes the annual report for the financial year 2019
LUND, SWEDEN - Immunovia has today published the annual report for 2019. It is available on Immunovia's website . Mats Grahn, CEO, comments: "In December 2019, we reached a very important milestone with the results of the “Commercial Test Model Study”, which showed 95% accuracy for IMMray™ PanCan–d, our product for diagnosing pancreatic cancer at an early stage when it is still possible to successfully remove the tumor surgically. This result paves the way for considerable improved treatment and survival rates for patients with